Structural requirements of flavonoids and related compounds for aldose reductase inhibitory activity.

The methanolic extracts of several natural medicines and medicinal foodstuffs were found to show an inhibitory effect on rat lens aldose reductase. In most cases, flavonoids were isolated as the active constituents by bioassay-guided separation, and among them, quercitrin (IC(50)=0.15 microM), guaijaverin (0.18 microM), and desmanthin-1 (0.082 microM) exhibited potent inhibitory activity. Desmanthin-1 showed the most potent activity, which was equivalent to that of a commercial synthetic aldose reductase inhibitor, epalrestat (0.072 microM). In order to clarify the structural requirements of flavonoids for aldose reductase inhibitory activity, various flavonoids and related compounds were examined. The results suggested the following structural requirements of flavonoid: 1) the flavones and flavonols having the 7-hydroxyl and/or catechol moiety at the B ring (the 3',4'-dihydroxyl moiety) exhibit the strong activity; 2) the 5-hydroxyl moiety does not affect the activity; 3) the 3-hydroxyl and 7-O-glucosyl moieties reduce the activity; 4) the 2-3 double bond enhances the activity; 5) the flavones and flavonols having the catechol moiety at the B ring exhibit stronger activity than those having the pyrogallol moiety (the 3',4',5'-trihydroxyl moiety).

[1]  H. Kolodziej,et al.  (+)-catechin 3-rhamnoside from Erythroxylum novogranatense , 1986 .

[2]  R. Ward,et al.  The carbon-13 nuclear magnetic resonance spectra of flavonoids and related compounds. , 1976, Journal of the Chemical Society. Perkin transactions 1.

[3]  H. Matsuda,et al.  Medicinal Foodstuffs. XXVI. Inhibitors of Aldose Reductase and New Triterpene and Its Oligoglycoside, Centellasapogenol A and Centellasaponin A, from Centella asiatica (Gotu Kola) , 2001 .

[4]  D. K. Bhardwaj,et al.  Myricetin 7,4′-dimethyl ether and its 3-galactoside from Rhus lancea , 1983 .

[5]  K. V. Rao,et al.  Partial methylation of quercetin: Direct synthesis of tamarixetin, ombuin and ayanin , 1976 .

[6]  H. Matsuda,et al.  Bioactive constituents of Chinese natural medicines. VII. Inhibitors of degranulation in RBL-2H3 cells and absolute stereostructures of three new diarylheptanoid glycosides from the bark of Myrica rubra. , 2002, Chemical & pharmaceutical bulletin.

[7]  I. Kitagawa,et al.  Saponin and sapogenol. L. On the constituents of the roots of Glycyrrhiza uralensis Fischer from Xinjiang, China. Chemical structures of licorice-saponin L3 and isoliquiritin apioside. , 1993, Chemical and pharmaceutical bulletin.

[8]  H. Itokawa,et al.  Studies on a Novel p-Coumaroyl Glucoside of Apigenin and on Other Flavonoids isolated from Patchouli (Labiatae) , 1981 .

[9]  H. Matsuda,et al.  New Noroleanane-Type Triterpene Saponins with Gastroprotective Effect and Platelet Aggregation Activity from the Flowers of Camellia Japonica: Revised Structures of Camellenodiol and Camelledionol , 2001 .

[10]  H. Schneider,et al.  Deprotonation induced 13 C NMR shifts in phenols and flavonoids , 1983 .

[11]  M. Hattori,et al.  Medicinal foodstuffs. XXIV. Chemical constituents of the processed leaves of Apocynum venetum L.: absolute stereostructures of apocynosides I and II. , 2001, Chemical & pharmaceutical bulletin.

[12]  H. Matsuda,et al.  Antidiabetic principles of natural medicines. III. Structure-related inhibitory activity and action mode of oleanolic acid glycosides on hypoglycemic activity. , 1998, Chemical & pharmaceutical bulletin.

[13]  C. Chen,et al.  New Flavones from Bauhinia championii BENTH. , 1984 .

[14]  Y. Asakawa.  Chemical Constituents of Alnus sieboldiana (BETULACEAE) II. The Isolation and Structure of Flavonoids and Stilbenes , 1971 .

[15]  H. Matsuda,et al.  Antidiabetic principles of natural medicines. V. Aldose reductase inhibitors from Myrcia multiflora DC. (2): Structures of myrciacitrins III, IV, and V. , 2002, Chemical & pharmaceutical bulletin.

[16]  K. Inagaki,et al.  Inhibition of aldose reductases from rat and bovine lenses by flavonoids. , 1982, Biochemical pharmacology.

[17]  H. Matsuda,et al.  Antioxidant constituents from rhubarb: structural requirements of stilbenes for the activity and structures of two new anthraquinone glucosides. , 2001, Bioorganic & medicinal chemistry.

[18]  I. Yosioka,et al.  Saponin and Sapogenol. XIII. Structures of Three Soybean Saponins : Soyasaponin I, Soyasaponin II, and Soyasaponin III , 1976 .

[19]  N. Turro,et al.  Photochemistry of 1,2-diphenyl-2,2-dimethyl-propanone-1 in micellar solutions. Cage effects, isotope effects and magnetic field effects. , 1980 .

[20]  K. L. Dhar,et al.  Flavonoid compounds from Piper peepuloides. , 1970, Planta Medica.

[21]  J. Kinoshita,et al.  Inhibition of lens aldose reductase by flavonoids--their possible role in the prevention of diabetic cataracts. , 1976, Biochemical pharmacology.

[22]  雅之 吉川,et al.  Salacia属植物のポリフェノール成分:α-グルコシダーゼ及びアルドースレダクターゼ阻害活性成分,Mangiferin,の定量分析 , 2001 .

[23]  H. Matsuda,et al.  Medicinal flowers. II. Inhibitors of nitric oxide production and absolute stereostructures of five new germacrane-type sesquiterpenes, kikkanols D, D monoacetate, E, F, and F monoacetate from the flowers of Chrysanthemum indicum L. , 2000, Chemical & pharmaceutical bulletin.

[24]  T. Nikaido,et al.  Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase by flavonoids. II. , 1988, Chemical & pharmaceutical bulletin.

[25]  I. Merfort,et al.  Thirty-seven flavonoids from flowers ofArnica longifolia , 1994 .

[26]  Kyung-Tae Lee,et al.  Isoflavone glycosides from the flowers of Puerariathunbergiana , 1999 .

[27]  J. F. Stevens,et al.  The systematic and evolutionary significance of exudate flavonoids in Aeonium , 1995 .

[28]  Y. Komoda.  Isolation of flavonoids from Populus nigra as delta 4-3-ketosteroid (5 alpha) reductase inhibitors. , 1989, Chemical & pharmaceutical bulletin.

[29]  I. Kitagawa,et al.  サポニン及びサポゲノール(第45報) : 槐花 (Sophorae Flos) の含有成分 : Kaikasaponin I, II 及び III の化学構造 , 1988 .

[30]  A. Konings.  FREE-RADICAL PATHOLOGY - AN INTRODUCTION , 1987 .

[31]  M. Yoshikawa,et al.  Antidiabetic principles of natural medicines. II. Aldose reductase and alpha-glucosidase inhibitors from Brazilian natural medicine, the leaves of Myrcia multiflora DC. (Myrtaceae): structures of myrciacitrins I and II and myrciaphenones A and B. , 1998, Chemical & pharmaceutical bulletin.

[32]  S. Nishibe,et al.  Flavonoids from Rhamnus pallasii , 1983 .

[33]  R. C. Cambie,et al.  13C NMR spectra of polymethoxy‐ and methylenedioxyflavonols , 1979 .

[34]  R. Kikkawa,et al.  Effects of a new aldose reductase inhibitor on various tissues in vitro. , 1984, The Journal of pharmacology and experimental therapeutics.

[35]  H. Matsuda,et al.  Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages. , 2000, Bioorganic & medicinal chemistry letters.

[36]  H. Matsuda,et al.  Antidiabetic principles of natural medicines. IV. Aldose reductase and qlpha-glucosidase inhibitors from the roots of Salacia oblonga Wall. (Celastraceae): structure of a new friedelane-type triterpene, kotalagenin 16-acetate. , 1999, Chemical & pharmaceutical bulletin.

[37]  H. Matsuda,et al.  Inhibitors from rhubarb on lipopolysaccharide-induced nitric oxide production in macrophages: structural requirements of stilbenes for the activity. , 2001, Bioorganic & medicinal chemistry.

[38]  J. Kinoshita,et al.  Flavonoids as inhibitors of lens aldose reductase. , 1975, Science.

[39]  H. Matsuda,et al.  Medicinal flowers. I. Aldose reductase inhibitors and three new eudesmane-type sesquiterpenes, kikkanols A, B, and C, from the flowers of Chrysanthemum indicum L. , 1999, Chemical & pharmaceutical bulletin.

[40]  M. Nawwar,et al.  The flavonoids of phragmites australis flowers , 1980 .

[41]  N. Murakami,et al.  Bioactive saponins and glycosides. VII. On the hypoglycemic principles from the root cortex of Aralia elata Seem.: structure related hypoglycemic activity of oleanolic acid oligoglycoside. , 1996, Chemical & pharmaceutical bulletin.